Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm
NCT06608186
Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS?! (PPOS)
Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS Cases
Sponsor: Ahmed Saad
Conditions
PCOS (Polycystic Ovary Syndrome)
Interventions
Cetrorelix drug Drospirenone drug
Updated 2 times since 2024 Last updated: Jan 19, 2025 Started: Oct 1, 2024 Primary completion: Jan 19, 2025 Completion: Jan 19, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06608186, this PHASE1/PHASE2 trial focuses on PCOS (Polycystic Ovary Syndrome) and remains completed. Sponsored by Ahmed Saad, it has been updated 2 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
2 versions recorded-
Feb 2025 — Present [monthly]
Completed PHASE1/PHASE2
Status: Not Yet Recruiting → Completed
-
Oct 2024 — Feb 2025 [monthly]
Not Yet Recruiting PHASE1/PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Ahmed Saad
Data source: Benha University
For direct contact, visit the study record on ClinicalTrials.gov .